How Do Inhaled Corticosteroids Benefit Infants With Established Bronchopulmonary Dysplasia (BPD)?
Question
How do inhaled corticosteroids benefit infants with established bronchopulmonary dysplasia (BPD)?
Answer
Inhaled corticosteroids are increasingly utilized in treating infants with established bronchopulmonary dysplasia (BPD) due to their positive impact on patient outcomes, particularly in reducing the incidence of chronic lung disease. A Cochrane Systematic Review highlights that early administration of inhaled steroids to very low birth weight infants can decrease the likelihood of death or chronic lung disease at 36 weeks postmenstrual age. However, to optimize the benefits while minimizing risks, it is essential to carefully evaluate the dosing and delivery methods. The potential neurodevelopmental risks associated with inhaled steroids necessitate a thorough risk-benefit analysis, emphasizing the need for individualized treatment plans and further research to refine their use.
Katlyn Burr
MSM-HCA, RRT, RRT-NPS, AE-C
Related Courses
Reducing Unplanned Extubation in Pediatric Patients
Unplanned extubation (UE) can be a critical and potentially life-threatening event for pediatric patients relying on mechanical ventilation. This comprehensive course is designed to equip healthcare professionals with the knowledge and skills necessary to understand, prevent, and manage unplanned extubation incidents in pediatric populations.Heart of the Matter: Exploring Congenital Cardiac Defects
The congenital cardiac defects course delves into the anatomy, diagnosis, and treatment of congenital heart abnormalities, highlighting the latest research and advancements in medical care. This course aims to enhance respiratory therapists' understanding and awareness of the complexities and innovations in managing congenital cardiac conditions.Heliox Therapy For Intubated and Nonintubated Patients
Heliox therapy is frequently used to treat upper airway obstruction. This introductory course discusses the heliox application in the neonatal and pediatric populations, including evidence-based research on clinical use, procedures, and monitoring.